Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT03974113
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia
Interventions
DRUG:
Fitusiran
Sponsor
Genzyme, a Sanofi Company